Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Fortnite maker and Google settle five-year legal fight over Android app store
5/11/2025
Miscounting to six costs Tory stand-in his gotcha against poppy-shock Lammy | John Crace
5/11/2025
‘A lifeline’ : how fashion designers came to love the high street collab
5/11/2025
‘It’s for the girls and the gays !’ Rachel Sennott on her hilarious comedy about the grotty glamour of Gen Z life
5/11/2025
Almost 30% of people abused as children, England and Wales data shows
5/11/2025
We can’t let the Tories sabotage this once-in-a-generation chance to reshape the world of work | Angela Rayner
5/11/2025